25 May 2013
Keywords: neuro, biosci, buy, stake, cll, pharma, usa-based
Article | 14 April 2003
USA-based Neuro Bioscience has signed an agreement to acquire a minimumof 75% of the issued and outstanding share capital of CLL ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
14 April 2003
24 May 2013
© 2013 thepharmaletter.com